Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

NCT02377999 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02377999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02377999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2015
Completion date
November 30, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anogenital warts